$1.52
-0.08-5%
Actinium Pharmaceuticals (ATNM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.20 | $-0.22 | $-0.22 | $-0.23 |
| Actual | $0.89 | $-0.18 | $-0.19 | $-0.16 |
| Surprise | +545.0% | +18.2% | +13.6% | +30.4% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $35.0M | $0 | $0 | $90000 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.25 | $-0.24 |
| Revenue | ||
| Consensus | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 7, 2026 | $0.89 | $-0.20 | 545.0 % |
| Q1 | May 8, 2026 | $-0.18 | $-0.22 | 18.2 % |
| Q4 | Mar 30, 2026 | $-0.19 | $-0.22 | 13.6 % |
| Q3 | Nov 14, 2025 | $-0.16 | $-0.23 | 30.4 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 2, 2023 | $0 | $570.00K | -100.0 % |
| Q4 | Apr 3, 2023 | $0 | $1.03M | -100.0 % |